Davis Andrew's Form 4 filing
Ironwood Pharmaceuticals Inc (IRWD) · filed Nov 22, 2023
- Accession no.
- 0001209191-23-056446
- Filed
- Nov 22, 2023
- Trade date
- Nov 20, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $31.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Davis AndrewCIK 0001932525 | Officer (SVP, Chief Business Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 20, 2023 | Class A Common Stock | SSaleDisposed | −3,287 | $9.69 | −$31,851.03 | 217,374 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.